IM
Last reporting period 30 Sep, 2023
Updated —
Last price
—
Market cap $B
8.726
Exchange
XNAS - Nasdaq
0.0028 B
Last period CFO ,USD
107%
CFO has increased in 5 years
What is CFO ?
Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.
See also ImmunoGen
Company Analysis
IMGN valuation, rating, competitors, insights and company profile
Eyestock Rating
IMGN financial analysis by Eyestock methodology
Valuation
IMGN valuation using historical relative method
Statements
IMGN Income Statements, Balance Sheet and Cash Flow Statements
Dividends
IMGN dividend yield and annual dividend
Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.
ImmunoGen`s CFO for the period ended 2023-09-30 is 0.0028 B USD
